PROGRAM
SESSION
BACK
SESSION
ABBVIE SYMPOSIUM: BRINGING HOPE TO PROC PATIENTS: THE JOURNEY WITH MIRVETUXIMAB SORAVTANSINE
MORE ON THE SESSION
DATE: 27-11-2025
TIME: 12:30 / 13:30
DURATION: 1 hour and 0 minutos
LOCATION: Room B
MODERATOR(S)
- Deolinda Pereira, IPO Porto
LECTURE(S)
ROUNDTABLE – THE JOURNEY OF THE OVARIAN CANCER PATIENT: THE IMPORTANCE OF A MULTIDISCIPLINARY APPROACH THROUGH A CLINICAL CASE
PLATINUM-RESISTANT OVARIAN CANCER (PROC) AND THE FUTURE WITH MIRVETUXIMAB SORAVTANSINE - CLINICAL CASE DESCRIPTION
- Mafalda Casa-Nova, ULS Loures-Odivelas
BIOMARKERS IN THERAPEUTIC DECISION-MAKING – PERSONALIZED MEDICINE IN PROCESSES WITH FRACTURES
- Carla Bartosch, IPO Porto
THE ROLE OF OPHTHALMOLOGY IN PATIENT MANAGEMENT
- Madalena Gonçalves , ULS Loures-Odivelas
CLOSING AND DISCUSSION
- Deolinda Pereira, IPO Porto